Cost-Effectiveness Analysis of Asciminib in Patients With Chronic Phase Chronic Myeloid Leukemia Previously Treated With 2 or More Tyrosine Kinase Inhibitors in Colombia

Value in Health Regional Issues · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles